Vertex announces phase III study of VX-659, tezacaftor and ivacaftor for cystic fibrosis Feb. 22, 2018
Endoscopic and symptom improvement seen with apremilast in phase II ulcerative colitis trial Feb. 22, 2018
Phase IIa study of GWP-42006 in adults with focal seizures did not meet its primary endpoint Feb. 22, 2018
RSS